-
1
-
-
34548223215
-
Challenges and prospects of immunotherapy as cancer treatment [J]
-
1:CAS:528:DC%2BD2sXpvFWmsLw%3D 17720322
-
M. Rescigno F. Avogadri G. Curigliano 2007 Challenges and prospects of immunotherapy as cancer treatment [J] Biochim Biophys Acta 1776 108 123 1:CAS:528:DC%2BD2sXpvFWmsLw%3D 17720322
-
(2007)
Biochim Biophys Acta
, vol.1776
, pp. 108-123
-
-
Rescigno, M.1
Avogadri, F.2
Curigliano, G.3
-
2
-
-
38849123209
-
The Immune system, is it relevant to cancer development, progression and treatment[J]?
-
1:STN:280:DC%2BD1c7gt1egtQ%3D%3D
-
R.J. Prestwich F. Errington P. Hatfield, et al. 2008 The Immune system, is it relevant to cancer development, progression and treatment[J]? Clin Oncol(R Coll Radiol) 20 101 112 1:STN:280:DC%2BD1c7gt1egtQ%3D%3D
-
(2008)
Clin Oncol(R Coll Radiol)
, vol.20
, pp. 101-112
-
-
Prestwich, R.J.1
Errington, F.2
Hatfield, P.3
-
3
-
-
34547655817
-
Tumor immunoediting and immunosculpting pathways to cancer progression
-
DOI 10.1016/j.semcancer.2007.06.009, PII S1044579X0700034X
-
J.M. Reiman M. Kmieciak M.H. Manjili, et al. 2007 Tumor immunoediting and immuno-sculpting pathways to cancer progression[J] Semin Cancer Biol 17 275 287 1:CAS:528:DC%2BD2sXovFyjs7o%3D 10.1016/j.semcancer.2007.06.009 17662614 (Pubitemid 47211962)
-
(2007)
Seminars in Cancer Biology
, vol.17
, Issue.4
, pp. 275-287
-
-
Reiman, J.M.1
Kmieciak, M.2
Manjili, M.H.3
Knutson, K.L.4
-
4
-
-
33847609982
-
Tumour immunology
-
DOI 10.1016/j.coi.2007.02.013, PII S0952791507000210, Lymphocyte development/Tumour immunology
-
M.J. Smyth 2007 Tumour immunology[J] Curr Opin Immunol 19 200 202 1:CAS:528:DC%2BD2sXisleiu7Y%3D 10.1016/j.coi.2007.02.013 (Pubitemid 46356974)
-
(2007)
Current Opinion in Immunology
, vol.19
, Issue.2
, pp. 200-202
-
-
Smyth, M.J.1
-
5
-
-
0024819297
-
Molecular cloning of the high affinity calcium-binding protein (calreticulin) of skeletal muscle sarcoplasmic reticulum[J]
-
1:CAS:528:DyaK3cXhvFaqsr4%3D 2600080
-
L. Fliegel K. Burns D.H. MacLennan, et al. 1989 Molecular cloning of the high affinity calcium-binding protein (calreticulin) of skeletal muscle sarcoplasmic reticulum[J] J Biol Chem 264 21522 21528 1:CAS:528: DyaK3cXhvFaqsr4%3D 2600080
-
(1989)
J Biol Chem
, vol.264
, pp. 21522-21528
-
-
Fliegel, L.1
Burns, K.2
MacLennan, D.H.3
-
6
-
-
0027955571
-
Modulation of gene expression by calreticulin binding to the glucocorticoid receptor
-
DOI 10.1038/367476a0
-
K. Burns B. Duggan E.A. Atkinson, et al. 1994 Modulation of gene expression by calreti-culin binding to the glucocorticoid receptor[J] Nature 367 476 480 1:CAS:528:DyaK2cXht1GgsLY%3D 10.1038/367476a0 8107808 (Pubitemid 24046052)
-
(1994)
Nature
, vol.367
, Issue.6462
, pp. 476-480
-
-
Burns, K.1
Duggan, B.2
Atkinson, E.A.3
Famulski, K.S.4
Nemer, M.5
Bleackley, R.C.6
Michalak, M.7
-
8
-
-
0032482319
-
Evidence for successive peptide binding and quality control stages during MHC class i assembly[J]
-
1:CAS:528:DyaK1cXjslegs74%3D 10.1016/S0960-9822(98)70280-5 9637925
-
J.W. Lewis T. Elliott 1998 Evidence for successive peptide binding and quality control stages during MHC class I assembly[J] Curr Biol 8 717 720 1:CAS:528:DyaK1cXjslegs74%3D 10.1016/S0960-9822(98)70280-5 9637925
-
(1998)
Curr Biol
, vol.8
, pp. 717-720
-
-
Lewis, J.W.1
Elliott, T.2
-
9
-
-
0033546416
-
Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules
-
DOI 10.1074/jbc.274.24.16917
-
F.A. Arosa O. deJesus G. Porto, et al. 1999 Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex I molecules[J] J Biol Chem 274 16917 16922 1:CAS:528:DyaK1MXjvVGkt7k%3D 10.1074/jbc.274.24.16917 10358038 (Pubitemid 29275144)
-
(1999)
Journal of Biological Chemistry
, vol.274
, Issue.24
, pp. 16917-16922
-
-
Arosa, F.A.1
De Jesus, O.2
Porto, G.3
Carmo, A.M.4
De Sousa, M.5
-
10
-
-
0034655278
-
Perforin lytic activity is controlled by calreticulin[J]
-
1:CAS:528:DC%2BD3cXis1Wksro%3D 10754310
-
S.A. Fraser R. Karimi M. Michalak, et al. 2000 Perforin lytic activity is controlled by calreticulin[J] J Immunol 164 4150 4155 1:CAS:528: DC%2BD3cXis1Wksro%3D 10754310
-
(2000)
J Immunol
, vol.164
, pp. 4150-4155
-
-
Fraser, S.A.1
Karimi, R.2
Michalak, M.3
-
11
-
-
58149287647
-
Transcriptional control of the calreticulin gene in health and disease[J]
-
1:CAS:528:DC%2BD1MXns1Oqtw%3D%3D 10.1016/j.biocel.2008.06.020 18765291
-
Y. Qiu M. Michalak 2009 Transcriptional control of the calreticulin gene in health and disease[J] Int J Biochem Cell Biol 41 531 538 1:CAS:528: DC%2BD1MXns1Oqtw%3D%3D 10.1016/j.biocel.2008.06.020 18765291
-
(2009)
Int J Biochem Cell Biol
, vol.41
, pp. 531-538
-
-
Qiu, Y.1
Michalak, M.2
-
12
-
-
0035797881
-
Apoptotic cell removal
-
DOI 10.1016/S0960-9822(01)00474-2
-
P.M. Henson D.L. Bratton V.A. Fadok 2001 Apoptotic cell removal[J] Curr Biol 11 R795 R805 1:CAS:528:DC%2BD3MXnsF2msro%3D 10.1016/S0960-9822(01)00474-2 11591341 (Pubitemid 32931008)
-
(2001)
Current Biology
, vol.11
, Issue.19
-
-
Henson, P.M.1
Bratton, D.L.2
Fadok, V.A.3
-
13
-
-
0035969234
-
Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells[J]
-
1:CAS:528:DC%2BD3MXosVKiurg%3D 10.1083/jcb.200108080 11706053
-
P.R. Hoffmann A.M. deCathelineau C.A. Ogden, et al. 2001 Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells[J] J Cell Biol 155 649 659 1:CAS:528:DC%2BD3MXosVKiurg%3D 10.1083/jcb.200108080 11706053
-
(2001)
J Cell Biol
, vol.155
, pp. 649-659
-
-
Hoffmann, P.R.1
Decathelineau, A.M.2
Ogden, C.A.3
-
14
-
-
0035903289
-
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells
-
DOI 10.1084/jem.194.6.781
-
C.A. Ogden A. deCathelineau P.R. Hoffmann, et al. 2001 C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macro-pinocytosis and uptake of apoptotic cells[J] J Exp Med 194 781 795 1:CAS:528:DC%2BD3MXmvFGgsrc%3D 10.1084/jem.194.6.781 11560994 (Pubitemid 32983014)
-
(2001)
Journal of Experimental Medicine
, vol.194
, Issue.6
, pp. 781-795
-
-
Ogden, C.A.1
DeCathelineau, A.2
Hoffmann, P.R.3
Bratton, D.4
Fadok, B.5
Ghebrehiwet, V.A.6
Henson, P.M.7
-
15
-
-
77955550333
-
A Mechanism of Release of Calreticulin from Cells during Apoptosis[J]
-
1:CAS:528:DC%2BC3cXhtVaqs7vP 10.1016/j.jmb.2010.06.064 20624402
-
J.M. Tarr P.J. Young P. Eggleton, et al. 2010 A Mechanism of Release of Calreticulin from Cells During Apoptosis[J] J Mol Biol 401 799 812 1:CAS:528:DC%2BC3cXhtVaqs7vP 10.1016/j.jmb.2010.06.064 20624402
-
(2010)
J Mol Biol
, vol.401
, pp. 799-812
-
-
Tarr, J.M.1
Young, P.J.2
Eggleton, P.3
-
16
-
-
26844468253
-
Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte
-
DOI 10.1016/j.cell.2005.08.032, PII S009286740500869X
-
S.J. Gardai K.A. McPhillips S.C. Frasch, et al. 2005 Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte[J] Cell 123 321 334 1:CAS:528:DC%2BD2MXhtFOqsbfN 10.1016/j.cell.2005.08.032 16239148 (Pubitemid 41457220)
-
(2005)
Cell
, vol.123
, Issue.2
, pp. 321-334
-
-
Gardai, S.J.1
McPhillips, K.A.2
Frasch, S.C.3
Janssen, W.J.4
Starefeldt, A.5
Murphy-Ullrich, J.E.6
Bratton, D.L.7
Oldenborg, P.-A.8
Michalak, M.9
Henson, P.M.10
-
17
-
-
33846057130
-
Calreticulin exposure dictates the immunogenicity of cancer cell death
-
DOI 10.1038/nm1523, PII NM1523
-
M. Obeid A. Tesniere F. Ghiringhelli, et al. 2007 Calreticulin exposure dictates the immunoenicity of cancer cell death[J] Nat Med 13 54 61 1:CAS:528:DC%2BD2sXhvFWisw%3D%3D 10.1038/nm1523 17187072 (Pubitemid 46067386)
-
(2007)
Nature Medicine
, vol.13
, Issue.1
, pp. 54-61
-
-
Obeid, M.1
Tesniere, A.2
Ghiringhelli, F.3
Fimia, G.M.4
Apetoh, L.5
Perfettini, J.-L.6
Castedo, M.7
Mignot, G.8
Panaretakis, T.9
Casares, N.10
Metivier, D.11
Larochette, N.12
Van Endert, P.13
Ciccosanti, F.14
Piacentini, M.15
Zitvogel, L.16
Kroemer, G.17
-
18
-
-
62049085194
-
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death[J]
-
1:CAS:528:DC%2BD1MXosVWltw%3D%3D 10.1038/emboj.2009.1 19165151
-
T. Panaretakis O. Kepp G. Kroemer, et al. 2009 Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death[J] EMBO J 28 578 590 1:CAS:528:DC%2BD1MXosVWltw%3D%3D 10.1038/emboj.2009.1 19165151
-
(2009)
EMBO J
, vol.28
, pp. 578-590
-
-
Panaretakis, T.1
Kepp, O.2
Kroemer, G.3
-
19
-
-
73649107916
-
Mitoxantrone-Mediated Apoptotic B16-F1 Cells Induce Specific Anti-tumor Immune Response[J]
-
1:CAS:528:DC%2BC3cXht1OisLs%3D 10.1038/cmi.2009.59
-
Y. Cao Y. Han Y. Wang, et al. 2009 Mitoxantrone-Mediated Apoptotic B16-F1 Cells Induce Specific Anti-tumor Immune Response[J] Cell Mol Immuno 6 469 475 1:CAS:528:DC%2BC3cXht1OisLs%3D 10.1038/cmi.2009.59
-
(2009)
Cell Mol Immuno
, vol.6
, pp. 469-475
-
-
Cao, Y.1
Han, Y.2
Wang, Y.3
-
20
-
-
14144251611
-
Molecular mechanisms of polyamine analogs in cancer cells
-
DOI 10.1097/00001813-200503000-00002
-
Y. Huang A. Pledgie R.A. Casero Jr, et al. 2005 Molecular mechanisms of polyamine analogs in cancer cells[J] Anticancer Drugs 16 229 241 1:CAS:528:DC%2BD2MXht1Omsbk%3D 10.1097/00001813-200503000-00002 15711175 (Pubitemid 40283938)
-
(2005)
Anti-Cancer Drugs
, vol.16
, Issue.3
, pp. 229-241
-
-
Huang, Y.1
Pledgie, A.2
Casero Jr., R.A.3
Davidson, N.E.4
-
21
-
-
34248228763
-
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
-
DOI 10.1038/nrd2243, PII NRD2243
-
R.A. Casero L.J. Marton 2007 Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases[J] Nat Rev Drug Discov 6 373 390 1:CAS:528:DC%2BD2sXkslyiu7k%3D 10.1038/nrd2243 17464296 (Pubitemid 46705201)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.5
, pp. 373-390
-
-
Casero, R.A.1
Marton, L.J.2
-
22
-
-
30144433680
-
Significance of targeting polyamine metabolism as an antineoplastic strategy: Unique targets for polyamine analogues[J]
-
1:CAS:528:DC%2BD28Xpt12ksw%3D%3D 16416654
-
R.A. Casero Jr B. Frydman T.M. Stewart, et al. 2005 Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues[J] Proc West Pharmacol Soc 48 24 30 1:CAS:528: DC%2BD28Xpt12ksw%3D%3D 16416654
-
(2005)
Proc West Pharmacol Soc
, vol.48
, pp. 24-30
-
-
Casero Jr., R.A.1
Frydman, B.2
Stewart, T.M.3
-
23
-
-
77953701142
-
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway[J]
-
1:CAS:528:DC%2BC3cXntlKrurY%3D 10.1158/1078-0432.CCR-09-2891 20421432
-
L. Zitvogel O. Kepp L. Senovilla, et al. 2010 Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway[J] Clin Cancer Res 16 3100 3104 1:CAS:528:DC%2BC3cXntlKrurY%3D 10.1158/1078-0432.CCR-09- 2891 20421432
-
(2010)
Clin Cancer Res
, vol.16
, pp. 3100-3104
-
-
Zitvogel, L.1
Kepp, O.2
Senovilla, L.3
|